Clinical trials
Observational Primary Myelofibrosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 9 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 4 |
| Icahn School of Medicine at Mount Sinai | 3 |
| University of Utah | 3 |
| Vanderbilt-Ingram Cancer Center | 3 |
| National Human Genome Research Institute (NHGRI) | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Vanderbilt University | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Case Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 35 |
| Myeloproliferative Disorders | 24 |
| Blast Crisis | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 16 |
| Leukemia, Myeloid, Accelerated Phase | 16 |
| Leukemia, Myeloid, Acute | 16 |
| Lymphoma, B-Cell, Marginal Zone | 16 |
| Lymphoma, Follicular | 16 |
| Lymphoma, Mantle-Cell | 16 |
| Lymphoma, Non-Hodgkin | 16 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.